Oral Traditional Chinese Medicine Combined with Retained Enema of Qing Kui Decoction Treatment on Patients with Ulcerative Colitis

XI Zuo-wu

doi:10.13422/j.cnki.syfjx.2014190198

您当前的位置：

首页 >

文章列表页 >

Oral Traditional Chinese Medicine Combined with Retained Enema of Qing Kui Decoction Treatment on Patients with Ulcerative Colitis

更新时间：2024-01-04

- Oral Traditional Chinese Medicine Combined with Retained Enema of Qing Kui Decoction Treatment on Patients with Ulcerative Colitis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 19, Pages: 198-201(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014190198
  CLC： R259
- Published：2014
- 稿件说明：
移动端阅览
XI Zuo-wu. Oral Traditional Chinese Medicine Combined with Retained Enema of Qing Kui Decoction Treatment on Patients with Ulcerative Colitis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(19): 198-201.
DOI：

XI Zuo-wu. Oral Traditional Chinese Medicine Combined with Retained Enema of Qing Kui Decoction Treatment on Patients with Ulcerative Colitis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(19): 198-201. DOI： 10.13422/j.cnki.syfjx.2014190198.

摘要

目的：探讨中药内服联合清溃方保留灌肠诱导和维持治疗溃疡性结肠炎（UC）的近期和远期疗效。方法：将160例UC患者随机按数字表法分为西药组和中药组各80例。西药组采用口服柳氮磺胺吡啶片+强的松治疗，疗程8周，对治疗达到缓解期患者再以柳氮磺胺吡啶片维持治疗2个月；中药组采用中药内服联合清溃方保留灌肠，疗程8周，对经治疗达到缓解期患者再根据不同证型以中成药维持治疗8周。对进入缓解期患者进行12个月随访。进行治疗前后结肠镜检查，以结肠镜Baron内镜评分法进行评价；采用肠黏膜病变活动指数（Sutherland）评估疾病严重度与活动度；采用炎症性肠病问卷（IBDQ）评价生活质量；对主要症状、体征进行治疗前后评分，记录患者复发次数。结果：中药组临床疗效总有效率为91.2%，西药组为75%，中药组优于西药组（P<0.05）；中药组Baron评分和Sutherland疾病活动指数评分低于西药组（P<0.01）；中药组腹泻、脓血便和腹痛评分低于西药组（P<0.01）；中药组IBDQ量表肠道症状、全身症状、情感能力和社会能力评分及总分均高于西药组（P<0.01）；中药组12个月内复发频率为（0.76±0.41）次少于西药组的（1.28±0.64）（P<0.01）。结论：中药内服联合清溃方保留灌肠诱导和维持治疗溃疡性结肠炎能控制UC活动，促进溃疡愈合，控制临床症状，并能降低复发率。

Abstract

Objective: To discuss the short-term and long-term effects of oral traditional Chinese medicine combined with retention enema of Qingkui decoction in treating patients with ulcerative colitis (UC). Method: One hundred and sixty patients with UC were randomly divided into control group and observation group of 80 patients each. Patients in control group received oral sulfasalazine tablets plus prednisone for 8 weeks

then received maintenance treatment with sulfasalazine tablets for 2 months for patients in remission. Patients in observation group received oral traditional Chinese medicine combined with retention enema of Qingkui decoction for 8 weeks

then received maintenance treatment with corresponding Chinese patent medicines according to differentiated syndrome for 8 weeks for patients in remission. And patients in remission received a 12 month follow-up. Before and after treatment

colonoscopy was performed and the results were evaluated by Baron scoring method. The disease activity was scored by Sutherland DAI. Quality of life in inflammatory bowel disease (IBD) was assessed by IBD questionnaire (IBDQ). The main signs and symptoms

were scored

and the recurrence rate of patients was recorded. Result: The total effective rate in observation group was 91.2% superior to 75% in control group(P<0.05). Baron score and Sutherland DAI score in observation group were lower than those in control group (P<0.01). The score of diarrhea

bloody purulent stool and stomachache in observation group were lower than those in control group (P<0.01). IBDQ scores including intestinal tract symptom

constitutional symptom

emotional capability and social competence in observation group were higher than those in control group (P<0.01). Recurrence rate in observation group within 12 months was (0.76±0.41) less than (1.28±0.64) in control group (P<0.01). Conclusion: Induction and maintenance treatment of oral Chinese patent medicine combined with retention enema of Qingkui decoction is an effective therapy to prevent the activity of UC

improve the healing of anabrosis

control clinical symptoms and reduce recurrence rate.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Observation on Jiechang Qingre Pills Combined with Conventional Western Medicine Therapy in Improving Dampness-heat Syndrome of Large Intestine at Active Stage of Ulcerative Colitis

Clinical Effect of Modified Treatment of Shaoyao Tang Retention Enema Combined with Mesalazine on Ulcerative Colitis with Large Intestine Damp-heat

Effect of Retention Enema of Yuchang Decoction Combined Mesalazine in Treating 60 Patients with Ulcerative Colitis

Nano Oral Colon Targeted Drug Delivery System in Treatment of Ulcerative Colitis： A Review

Comparison of Pharmacokinetics and Tissue Distribution of Free Anthraquinones and Gallic Acid in Mice with Ulcerative Colitis Before and After Processing of Rhei Radix et Rhizoma Carbonisata

Related Author

Ya-juan YANG

Kai WANG

Zuo-wu XI

Zong-yue GAO

QI Xue-yang

ZHANG Qin-sheng

ZHANG Chun-yan

NING Yu-feng

Related Institution

Second Clinical Medical College， Henan University of Chinese Medicine

Henan Province Hospital of TCM The Second Affiliated Hospital of Henan University of Chinese Medicine

Jiangxi University of Chinese Medicine

College of Food Science and Technology，Nanchang University

School of Life Sciences，Beijing University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰